Printer Friendly

Browse Cytarabine topic

 

Articles

1-19 out of 19 article(s)
Title Author Type Date Words
BioSight Completed Patient Enrollment and Treatment in its Extended Acute Leukemia Phase I/II Clinical Trial with BST-236, a Novel Cytarabine Pro-Drug. Aug 9, 2017 564
Event 1132-1116, cytarabine (cytosine arabinoside) solution for injection or powder for parenteral use. Feb 21, 2016 105
Analysis Of Phase 2 Tosedostat In Combination With Low Dose Cytarabine Shows High Rates Of Response In Elderly Patients With AML. Dec 6, 2015 1639
2727-2015 list cytarabine (cytosine arabinoside) injectable solution or powder for parenteral use 100 mg / ml vial or ampule code 671. Nov 23, 2015 115
Event 3815/2015 cytarabine (cytosine arabinoside) solution for injection or powder for parenteral use 100 mg / ml vial or ampule. Oct 24, 2015 116
1883-2015 list cytarabine (cytosine arabinoside) injectable solution or powder for parenteral use 100 mg / ml vial or ampule code 671. Aug 14, 2015 115
Oxaliplatin Market and Global Cytarabine Industry Forecasts to 2020. Jul 10, 2015 1056
Tosedostat In Combination With Low Dose Cytarabine Achieves Primary Endpoint In Phase 2 Study In Elderly Patients With AML. Jun 15, 2015 2012
Event 1851/2015 cytarabine (cytosine arabinoside) injection or dust for parenteral use 100 mg / ml vial or ampule. May 12, 2015 115
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Initiates Randomized Phase 2 Trial Evaluating Tosedostat plus Cytarabine for Older Patients with AML or High-Risk MDS. Jun 12, 2014 1449
Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens/Konsolidaciona terapija akutne mijeloidne leukemije: visoke doze citozinarabinozida naspram drugih konsolidacionih rezima sa citozin-arabinozidom. Zeremski, Vanja; Savic, Aleksandar Report Mar 1, 2014 3495
Systemic mastocytosis with associated acute myelogenous leukemia. Zhrebker, Leah; Cooper, Barry; Krause, John R. Clinical report Jan 1, 2014 1490
High dose cytosin arabinoside induced sinus bradycardia in a Hodgkins lymphoma patient/Hodgkin lenfomali bir hastada yuksek doz sitozin arabinozid kullanimina bagli gelisen sinus bradikardisi. Teke, Hava Uskudar; Karagulle, Mustafa; Akay, Olga Meltem Letter to the editor Sep 1, 2013 711
Corneal epithelial microcysts due to high-dose cytarabine administration in a pediatric acute myeloid leukemia patient / Pediatrik Akut Miyeloid Losemili Hastada Yuksek Doz Sitarabin Uygulamasina Bagli Korneal Epitel Mikrokistler. Karapmar, Tuba Hilkay; Gozmen, Salih; Tufekci, Ozlem; Yilmaz, Sebnem; Ozbek, Zeynep; Parlak, Melih; Clinical report Mar 1, 2012 768
Bedford Laboratories[TM] Issues Nationwide Voluntary Recall of Cytarabine for Injection, USP, 1 Gram Per Vial. Feb 16, 2012 709
Lower cytarabine dose offers equivalent response for AML. McBride, Deborah Report Jun 1, 2011 142
Wedgewood Pharmacy Will Compound Cytarabine, a Life-Saving Leukemia Drug in Critically Short-Supply. Apr 20, 2011 310
ARA-C associated pulmonary toxicity / ARA-C iliskili akciger toksisitesi. Yegin, Zeynep Arzu; Sucak, Gulsan Turkoz; Erbas, Gonca; Yagci, Munci Mar 1, 2011 1075
Hair-raising adjunct for chemotherapy. Jan 25, 1992 310

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters